Back
Kaival Brands Innovations Group Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
39
KAVL
Kaival Brands Innovations Group
Last Price:
$0.62
Seasonality Move:
262.23%
Sell
27
CRSP
CRISPR Therapeutics AG
Last Price:
$35.83
Seasonality Move:
14.03%
Sell
39
Kaival Brands Innovations Group (KAVL)
is a Sell
Is Kaival Brands Innovations Group a Buy, Sell or Hold?
-
The current Kaival Brands Innovations Group [KAVL] share price is $0.62. The Score for KAVL is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
KAVL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $35.60. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KAVL Stock Price Chart
What is Kaival Brands Innovations Group's stock price today?
-
The Kaival Brands Innovations Group share price today is $0.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KAVL is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $35.60The current trend is moderately bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
KAVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 64 | Buy |
Chaikin Money Flow: | -348 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.57) | Buy |
Bollinger Bands (100): | (0.52 - 1.1) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 45.1 | Sell |
Chaikin Money Flow: | -1833359 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.58 - 38.96) | Sell |
Bollinger Bands (100): | (36.39 - 44.27) | Sell |
KAVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Buy |
20-day SMA: | 0.53 | Buy |
50-day SMA: | 0.56 | Buy |
200-day SMA: | 0.83 | Sell |
8-day EMA: | 0.59 | Buy |
20-day EMA: | 0.56 | Buy |
50-day EMA: | 0.61 | Buy |
200-day EMA: | 1.28 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.9 | Sell |
20-day SMA: | 37.28 | Sell |
50-day SMA: | 38.28 | Sell |
200-day SMA: | 44.53 | Sell |
8-day EMA: | 36.4 | Sell |
20-day EMA: | 35.98 | Sell |
50-day EMA: | 29.12 | Buy |
200-day EMA: | 11.93 | Buy |
Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.
Kaival Brands Innovations Group Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |